Study for Efficacy and Safety Assessment of the Drug RADAMIN®VIRO for COVID-19 Postexposure Prophylaxis

NCT05722691 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

800

Enrollment

OTHER

Sponsor class

Conditions

COVID-19

Interventions

DRUG: Double-Stranded RNA sodium salt
DRUG: Placebo

Sponsor

Promomed, LLC